Treatment patterns and clinical outcomes of asciminib in a real-world multiresistant chronic myeloid leukemia patient population

被引:8
|
作者
Kockerols, Camille C. B. [1 ]
Janssen, Jeroen J. W. M. [2 ]
Blijlevens, Nicole M. A. [3 ]
Klein, Saskia K. [4 ]
van Hussen-Daenen, Laura G. M. [5 ]
van Gorkom, Gwendolyn G. Y. [6 ]
Smit, Willem M. [7 ]
van Balen, Peter [8 ]
Biemond, Bart J. [9 ]
Cruijsen, Marjan J. [10 ]
Corsten, Maarten F. [11 ]
te Boekhorst, Peter A. W. [12 ]
Koene, Harry R. [13 ]
van Sluis, Geerte L. [14 ]
Cornelissen, Jan J. [12 ]
Westerweel, Peter E. [1 ]
机构
[1] Albert Schweitzer Hosp, Dept Internal Med, Dordrecht, Netherlands
[2] Univ Amsterdam, Dept Hematol, locat VUMC, Med Ctr, Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Dept Hematol, Med Ctr, Nijmegen, Netherlands
[4] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands
[5] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, South Africa
[6] Maastricht Univ, Dept Hematol, Med Ctr, Maastricht, Netherlands
[7] Med Spectrum Twente, Dept Hematol, Enschede, Netherlands
[8] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands
[9] Univ Amsterdam, Dept Hematol, locat AMC, Med Ctr, Amsterdam, Netherlands
[10] Catharina Hosp, Dept Hematol, Eindhoven, Netherlands
[11] Meander Med Ctr, Dept Hematol, Amersfoort, South Africa
[12] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands
[13] St Antonius Hosp, Dept Hematol, Nieuwegein, Netherlands
[14] Isala Hosp, Dept Hematol, Zwolle, Netherlands
关键词
D O I
10.3324/haematol.2022.281386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:240 / 244
页数:5
相关论文
共 50 条
  • [1] Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States
    Atallah, Ehab L.
    Wei, David
    Latremouille-Viau, Dominick
    Rossi, Carmine
    Damon, Andrea
    Ferreira, Germano
    Guerin, Annie
    Jadhav, Kejal
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (03):
  • [2] Real-World Evaluation of Treatment Patterns and Clinical Outcomes Among Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Asciminib in US Clinical Practice
    Atallah, Ehab L.
    Wei, David
    Latremouille-Viau, Dominick
    Rossi, Carmine
    Damon, Andrea
    Ferreira, Germano
    Guerin, Annie
    Jadhav, Kejal
    BLOOD, 2023, 142
  • [3] Asciminib After Two or More Prior Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Real-World Evaluation of Treatment Patterns and Clinical Outcomes in US Clinical Practice
    Atallah, Ehab L.
    Wei, David
    Latremouille-Viau, Dominick
    Rossi, Carmine
    Damon, Andrea
    Ferreira, Germano
    Guerin, Annie
    Jadhav, Kejal
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S367 - S368
  • [4] Real-world toxicity and efficacy of asciminib in heavily pretreated patients with chronic myeloid leukemia
    Ishii, Yoshimi
    Fujisawa, Shin
    Miyazaki, Takuya
    Nakajima, Yuki
    Matsumura, Ayako
    Fujimaki, Katsumichi
    Suzuki, Taisei
    Hagihara, Maki
    Tanaka, Marika
    Hashimoto, Chizuko
    Nakajima, Hideaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (02) : 187 - 193
  • [5] Real-world study of imatinib treatment patterns and outcomes among veteran patients with chronic myeloid leukemia
    Shi, Lizheng
    Chen, Lei
    Sharma, Hari
    Marynchenko, Maryna
    Wu, Eric Q.
    Liu, Jinan
    Yang, Heidi
    Guo, Min Amy
    Vander Velde, Nancy S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Real-World Management of Chronic Myeloid Leukemia in Bosnia and Herzegovina: Treatment Patterns, Molecular Monitoring, and Outcomes
    Kurtovic-Kozaric, Amina
    Islamagic, Erna
    Hasic, Azra
    Mehinovic-Cavcic, Lejla
    Komic, Hana
    Kurtovic, Sabira
    BLOOD, 2022, 140 : 12218 - 12219
  • [7] Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network
    Sanz, A.
    Ayala, R.
    Hernandez, G.
    Lopez, N.
    Gil-Alos, D.
    Gil, R.
    Colmenares, R.
    Carreno-Tarragona, G.
    Sanchez-Pina, J.
    Alonso, R. A.
    Garcia-Barrio, N.
    Perez-Rey, D.
    Meloni, L.
    Calbacho, M.
    Cruz-Rojo, J.
    Pedrera-Jimenez, M.
    Serrano-Balazote, P.
    de la Cruz, J.
    Martinez-Lopez, J.
    BLOOD CANCER JOURNAL, 2022, 12 (06)
  • [8] Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network
    A. Sanz
    R. Ayala
    G. Hernández
    N. Lopez
    D. Gil-Alos
    R. Gil
    R. Colmenares
    G. Carreño-Tarragona
    J. Sánchez-Pina
    R. A. Alonso
    N. García-Barrio
    D. Pérez-Rey
    L. Meloni
    M. Calbacho
    J. Cruz-Rojo
    M. Pedrera-Jiménez
    P. Serrano-Balazote
    J. de la Cruz
    J. Martínez-López
    Blood Cancer Journal, 12
  • [9] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Xiao, Yue
    Huang, Ruijian
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [10] Treatment outcome in a population-based, 'real-world' cohort of patients with chronic myeloid leukemia
    Geelen, Inge G. P.
    Thielen, Noortje
    Janssen, Jeroen J. W. M.
    Hoogendoorn, Mels
    Roosma, Tanja J. A.
    Willemsen, Sten P.
    Visser, Otto
    Cornelissen, Jan J.
    Westerweel, Peter E.
    HAEMATOLOGICA, 2017, 102 (11) : 1842 - 1849